HealthDay News — Preterm infants, including those born late preterm, have a lower rate of completion of recommended vaccines by age 19 months, according to a study published online Aug. 7 in Pediatrics.

Annika M. Hofstetter, MD, PhD, MPH, from the University of Washington in Seattle, and colleagues conducted a retrospective cohort study involving 10,367 Washington state infants with birth hospitalizations during 2008 to 2013. Completion of the recommended 7-vaccine series by 19 months of age was compared for preterm infants and term/postterm infants (born at <37 weeks of gestation and born at 37 to 43 weeks of gestation, respectively).

Overall, 19.3% of the infants were born prematurely. The researchers found that compared with term/postterm infants, preterm infants had lower completion of the 7-vaccine series by 19 months (47.5 vs 54.0%; adjusted odds ratio, 0.77) and 36 months (63.6 vs 71.3%; adjusted odds ratio, 0.73). Compared with term/postterm infants, early preterm (23 to 33 weeks of gestation) and late preterm (34 to 36 weeks of gestation) infants had a lower rate of 7-vaccine series completion. Between-group differences were also seen for full influenza coverage by 19 months (early preterm, 47.7%; late-preterm, 41.5%; term/postterm, 44.7%).

Related Articles

“The reasons for this are unclear but could reflect parental and provider factors, such as perceptions of medical vulnerability, vaccine safety beliefs, understanding of current vaccine recommendations, and provider-family vaccine communication, as well as health care use patterns in these high-risk infants,” the authors write.

Abstract/Full Text (subscription or payment may be required)